自身免疫性肝炎的中醫(yī)辨證治療用藥特點(diǎn)及療效
發(fā)布時(shí)間:2018-02-04 22:16
本文關(guān)鍵詞: 自身免疫性肝炎 中醫(yī)辨證治療 療效 用藥特點(diǎn) 出處:《中華中醫(yī)藥學(xué)刊》2017年10期 論文類型:期刊論文
【摘要】:目的:分析中醫(yī)辨證治療自身免疫性肝炎的臨床藥特點(diǎn)并進(jìn)行臨床療效的觀察。方法:回顧性分析2013年6月—2016年10月醫(yī)院接受中醫(yī)辨證施治的93例自身免疫性肝炎患者的臨床資料,將所有研究對(duì)象按照治療時(shí)的辨證分型不同分為A、B、C 3組,分別采用的中藥方劑為黃芪建中湯加減、逍遙散合桃紅四物湯加減、一貫煎加減服用治療。觀察A、B、C 3組的用藥特點(diǎn)和療效。結(jié)果:A組總有效率85.19%,B組的總有效率為82.76%,C組總有效率為86.49%;3組患者在治療后,血清ALT、AST、GGT的水平均顯著降低;且均無藥物相關(guān)不良反應(yīng)發(fā)生。結(jié)論:中醫(yī)多以自身免疫性肝炎患者的臨床癥狀進(jìn)行辨證分型,用藥時(shí)多采用具有免疫調(diào)節(jié)、疏肝理氣、滋陰補(bǔ)腎、健脾等功效的藥物治療,且中醫(yī)辨證論治,對(duì)癥施藥治療自身免疫性肝炎時(shí)有優(yōu)良的臨床療效,安全性好。
[Abstract]:Objective: to analyze the clinical characteristics of TCM syndrome differentiation in the treatment of autoimmune hepatitis and to observe the clinical efficacy. The clinical data of 93 patients with autoimmune hepatitis treated by TCM syndrome differentiation from June 2013 to October 2016 were analyzed retrospectively. All the subjects were divided into three groups according to their syndrome differentiation and classification. The traditional Chinese medicine prescriptions were Huangqi Jianzhong decoction, Xiaoyao San and Taohong Siwu decoction respectively. To observe the drug characteristics and efficacy of group C _ 3. Results the total effective rate of group A was 85.19% and the total effective rate of group B was 82.76%. The total effective rate of group C was 86.49; After treatment, the level of serum alt ASTGT was significantly decreased in the three groups. Conclusion: Chinese medicine is mostly based on the clinical symptoms of patients with autoimmune hepatitis for syndrome differentiation, the use of medicine with immune regulation, soothe liver and qi, tonify yin and kidney. It has excellent clinical effect and good safety in treating autoimmune hepatitis by TCM differentiation of symptoms and signs and treatment of autoimmune hepatitis with invigorating spleen and so on.
【作者單位】: 河北省中醫(yī)院脾胃病二科;河北醫(yī)科大學(xué)研究生學(xué)院;河北中醫(yī)學(xué)院研究生學(xué)院;
【基金】:河北省科學(xué)技術(shù)研究與發(fā)展計(jì)劃項(xiàng)目(11276170)
【分類號(hào)】:R259
【正文快照】: 自身免疫性肝炎是有自身免疫系統(tǒng)缺陷造成的一種慢性肝炎,后期長發(fā)展位肝硬化。在女性群體中多發(fā),且多見于青少年期和婦女絕經(jīng)期[1]。其臨床癥狀為波動(dòng)性黃疸、高Y球蛋白血癥(血清免疫球蛋白G濃度增高為主)、出現(xiàn)循環(huán)自身抗體為特點(diǎn)[2],目前臨床臨床上治療此病的首選藥物為免
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李超;中藥治療自身免疫性肝炎7例[J];實(shí)用中醫(yī)內(nèi)科雜志;2002年04期
2 劉喜德,金實(shí);金實(shí)教授流氣和絡(luò)法治療自身免疫性肝炎經(jīng)驗(yàn)擷要[J];中國中醫(yī)藥信息雜志;2000年09期
3 張瑋,季光,王育群,邢練軍,王雨y,
本文編號(hào):1491296
本文鏈接:http://sikaile.net/zhongyixuelunwen/1491296.html
最近更新
教材專著